ONDCP Reports Sharp Drop in U.S. Overdose Deaths
CDC data shows overdose fatalities at their lowest level in roughly a decade, with a steady decline sustained for 39 consecutive months.
Updated on Nov. 20, 2026 in Substance Abuse

Live Poll
Do you think federal drug policy is effectively reducing overdose deaths?
The Office of National Drug Control Policy announced a significant decrease in U.S. drug overdose deaths, citing CDC data showing fatalities have reached their lowest level in approximately a decade. The ONDCP statement said the primary gains occurred over the last 18 months.
Why it matters
The current administration attributes the decline to border security and the dismantling of trafficking organizations, while researchers have linked the trend to policies that began under the prior administration. Medicaid, the primary funder of addiction services, faces pending cuts that the Congressional Budget Office estimates could leave up to 10 million Americans without health insurance.
CDC data shows a steady decline in overdose fatalities for 39 consecutive months beginning in early 2023, with the sharpest drop between early 2024 and spring 2025. The attribution of the trend to specific policies remains disputed, and the extent to which the decline will persist is not yet known.
The players
Office of National Drug Control Policy
The White House office that coordinates federal drug control efforts and sets national drug policy priorities across agencies.
The details
The ONDCP statement cites CDC figures showing overdose deaths at their lowest level in about a decade. The current administration uses military strikes against suspected smuggling vessels in the Caribbean and Eastern Pacific, while the prior administration used diplomatic agreements with China to restrict shipment of fentanyl precursor chemicals.
Timeline
Early 2023: Consecutive monthly declines in overdose fatalities begin, continuing for 39 months.
Early 2024 to spring 2025: The most significant rate of decline in overdose deaths occurs.
Last 18 months: The period in which ONDCP says the primary overdose gains occurred.
Health Landscape
Medicaid is the primary funder for addiction services in the United States, so pending cuts to the program bear directly on the treatment infrastructure. The Congressional Budget Office estimates those cuts could cause up to 10 million Americans to lose health insurance, a shift that would reach the same population that relies on publicly funded addiction care.
Readers who rely on Medicaid for addiction treatment could see changes to covered services if the pending cuts take effect. Anyone seeking treatment should confirm current coverage with their insurer or state Medicaid office, since the Congressional Budget Office projects coverage losses for millions of people.
The takeaway
Overdose trends can shift quickly with policy changes, so the recent decline is best understood as a measured trend rather than a settled outcome. Tracking both the CDC data and the Medicaid funding decisions will show whether treatment access keeps pace with the gains.
Further reading
For more on the health side of this trend, see Substance Abuse coverage across the United States.
Source note: This article includes information reported by PravdaReport.
Live Poll
Do you think federal drug policy is effectively reducing overdose deaths?






